Super Retail Group (ASX:SUL) Plans AUD165M Investment to Drive Digital & Retail Expansion

Super Retail Group Limited (ASX:SUL), a major Australian retailer specialising in auto parts, outdoor equipment, and sporting goods, released its financial results for the financial year 2024 (FY24). Despite rising living costs impacting discretionary spending, the company managed to achieve a 2.10% YoY increase …

Team Kalkine | 28 Jan 2025| Read Time : 10 Mins

Monash IVF Group (ASX:MVF) Forecasts FY25 Growth Driven by Fertility North Acquisition and Women’s Imaging Expansion

Monash IVF Group Limited (ASX:MVF) is an Australian provider of reproductive and fertility services. As a publicly listed company on the ASX, it delivers a wide range of specialised services, such as diagnostic obstetric and gynaecological ultrasound, along with advanced fertility treatments. The company …

Team Kalkine | 22 Jan 2025| Read Time : 10 Mins

West African Resources (ASX: WAF) Targets 494k Ounces Gold Production Annually by 2030

West African Resources Limited (ASX:WAF) is an ASX-listed company with a focus on the exploration, advancement and acquisition of gold projects in West Africa. The company targets gold production of nearly 4 million ounces in the next 10 years with annual production expected to …

Team Kalkine | 21 Jan 2025| Read Time : 10 Mins

Lindsay Australia (ASX:LAU) Posts Nearly 19% Revenue Growth Despite Profit Decline in FY24

Lindsay Australia Limited (ASX:LAU) is an ASX-listed company that is engaged in integrated transport, logistics, and rural supply services. For the financial year ending 30 June 2024 (FY24), LAU achieved revenue growth of 18.9% YoY to AUD 804.37 million, driven by higher sales in …

Team Kalkine | 20 Jan 2025| Read Time : 10 Mins

Neuren Pharmaceuticals (ASX:NEU) Expects DAYBUE™ Revenue Growth with Boost in Future Royalties Potential

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian company that focuses on developing innovative drug therapies for neurological disorders. The company’s product, DAYBUE™ (trofinetide), has received approval from the US FDA. Through the commercial success of DAYBUE™, the company expects to benefit from ongoing royalties …

Team Kalkine | 15 Jan 2025| Read Time : 10 Mins

Stanmore Resources (ASX:SMR) Secures Key Contracts and Expands Project Portfolio in Q3FY24

Stanmore Resources Ltd (ASX:SMR) is an ASX-listed mining company that produces and sells metallurgical coal, a critical raw material for steelmaking. Activities undertaken in the latest quarter In the third quarter of the financial year 2024 (Q3FY24), the company recorded 5.8Mt of Run-of-Mine (ROM) …

Team Kalkine | 14 Jan 2025| Read Time : 10 Mins

Treasury Wine (ASX:TWE) projects optimistic FY25 targets, strengthens global presence with strategic acquisitions

ASX-listed Treasury Wine Estates Limited (ASX:TWE) manages wine business through three key activities, wine production, grape growing and sourcing and wine marketing, sales and distribution. Recently, the company has expanded its portfolio through acquisition of DAOU – a luxury wine brand. Business integration is …

Team Kalkine | 13 Jan 2025| Read Time : 10 Mins

News